Literature DB >> 15976331

Molecular pathology of prostate cancer.

C Hughes1, A Murphy, C Martin, O Sheils, J O'Leary.   

Abstract

The molecular pathology of prostate cancer is complex; not only are multiple genes involved in its pathogenesis, but additional environmental factors such as diet and inflammation are also involved. The exhaustive research into prostate cancer to date has demonstrated a complex interaction of multiple genes and environmental factors, some of which may be more important in individual prostate cancer cases. This is an exciting era, with the emergence of new investigative tools such as DNA microarray technology and the application of the field of proteomics to the study of human cancers. Knowledge of genetic changes underlying the initiation, development, and progression of prostate cancer is accumulating rapidly. With increasing knowledge, it may be possible to distinguish indolent from aggressive prostate tumours by molecular fingerprinting. This review discusses the most consistently reported molecular pathological findings in hereditary and sporadic prostate cancer, together with new concepts and technologies.

Entities:  

Mesh:

Year:  2005        PMID: 15976331      PMCID: PMC1770715          DOI: 10.1136/jcp.2002.003954

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  162 in total

1.  Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells.

Authors:  Robert E Bakin; Daniel Gioeli; Robert A Sikes; Eric A Bissonette; Michael J Weber
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

2.  Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy.

Authors:  Geert J L H van Leenders; Wesley R Gage; Jessica L Hicks; Bianca van Balken; Tilly W Aalders; Jack A Schalken; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

Authors:  A M De Marzo; A K Meeker; J I Epstein; D S Coffey
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 4.  Pathological and molecular aspects of prostate cancer.

Authors:  Angelo M DeMarzo; William G Nelson; William B Isaacs; Jonathan I Epstein
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

Review 5.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

6.  CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.

Authors:  Adam S Kibel; Brian K Suarez; Jay Belani; Joe Oh; Raul Webster; Michele Brophy-Ebbers; Chan Guo; William J Catalona; Joel Picus; Paul J Goodfellow
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

7.  EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.

Authors:  Xin A Zhang; William S Lane; Stephanie Charrin; Eric Rubinstein; Lei Liu
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

8.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.

Authors:  H Zhou; J Kuang; L Zhong; W L Kuo; J W Gray; A Sahin; B R Brinkley; S Sen
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.

Authors:  Yasuyoshi Fujiuchi; Osamu Nagakawa; Koji Murakami; Hideki Fuse; Ikuo Saiki
Journal:  Oncol Rep       Date:  2003 Jul-Aug       Impact factor: 3.906

10.  Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.

Authors:  Ceshi Chen; Eija-Riitta Hyytinen; Xiaodong Sun; Heikki J Helin; Pasi A Koivisto; Henry F Frierson; Robert L Vessella; Jin-Tang Dong
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more
  46 in total

1.  Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.

Authors:  Jia-hong Chen; Hui-chan He; Fu-neng Jiang; Julia Militar; Petor-yang Ran; Guo-qiang Qin; Chao Cai; Xi-Bin Chen; Jin Zhao; Zi-yao Mo; Yan-ru Chen; Jian-guo Zhu; Xingyin Liu; Wei-de Zhong
Journal:  Med Oncol       Date:  2011-10-30       Impact factor: 3.064

2.  Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.

Authors:  Safwan Escaff; Jesús M Fernández; Luis O González; Aurelio Suárez; Salomé González-Reyes; José M González; Francisco J Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

3.  MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.

Authors:  Yanjun Xu; Rui Hou; Qijie Lu; Yang Zhang; Lei Chen; Yuanyi Zheng; Bing Hu
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

4.  Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancer.

Authors:  Chao Cai; Fu-neng Jiang; Yu-xiang Liang; Hui-chan He; Zhao-dong Han; Qi-shan Dai; Guo-qiang Qin; Jia-hong Chen; Xi-bin Chen; Yan-ru Chen; Guo-hua Zeng; Jian-guo Zhu; Wei-de Zhong
Journal:  Pathol Oncol Res       Date:  2011-04-16       Impact factor: 3.201

5.  Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.

Authors:  Zhaohui He; Fucai Tang; Zechao Lu; Yucong Huang; Hanqi Lei; Zhibiao Li; Guohua Zeng
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

6.  Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.

Authors:  Jianjun Zhang; Ishwori B Dhakal; Nicholas P Lang; Fred F Kadlubar
Journal:  Cancer Causes Control       Date:  2010-04-30       Impact factor: 2.506

7.  Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy.

Authors:  Mohammad R Noori-Daloii; Majid Momeny; Mehdi Yousefi; Forough Golsaz Shirazi; Mehdi Yaseri; Nasrin Motamed; Nazanin Kazemialiakbar; Saeed Hashemi
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

8.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.

Authors:  Carlos S Moreno
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

9.  Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.

Authors:  J F Magalhães; A J Cortinhas; C M Albuquerque; C S Baptista; R Ribeiro; Carlos Viegas; Augusto Matos; João Machado; Maria A Pires; Henrique Guedes-Pinto; A Martins-Bessa; J C Leitão; E Bastos
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

10.  Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Authors:  S Escaff; J M Fernández; L O González; A Suárez; S González-Reyes; J M González; F J Vizoso
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.